von der Lippe Gythfeldt H, Lien T, Tekpli X, Silwal-Pandit L, et al. Immune phenotype of tumor microenvironment predicts response to bevacizumab in neoadjuvant treatment of ER positive breast cancer. Int J Cancer 2020 Jun 3. doi: 10.1002/ijc.33108.
PMID: 32488909